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Abstract 1 
Mass spectrometry (MS) based quantitative approaches typically require a thorough sample clean-2 
up and a decent chromatographic step in order to achieve needed figures of merit. However, in most cases, 3 
such processes are not optimal for urgent assessments and high-throughput determinations. The direct 4 
coupling of solid phase microextration (SPME) to MS has shown great potential to shorten the total sample 5 
analysis time of complex matrices, as well as to diminish potential matrix effects and instrument 6 
contamination.  In this study, we demonstrate the use of the open-port probe (OPP) as a direct and robust 7 
sampling interface to couple biocompatible-SPME (Bio-SPME) fibers to MS for the rapid quantitation of 8 
opioid isomers (i.e. codeine and hydrocodone) in human plasma. In place of chromatography, a differential 9 
mobility spectrometry (DMS) device was implemented to provide the essential selectivity required to 10 
quantify these constitutional isomers. Taking advantage of the simplified sample preparation process based 11 
on Bio-SPME and the fast separation with DMS-MS coupling via OPP, a high-throughput assay (10-15 12 
seconds per sample) with limits of detection in the sub-ng/mL range was developed. Succinctly, we 13 
demonstrated that by tuning adequate ion mobility separation conditions, SPME-OPP-MS can be employed 14 
to quantify non-resolved compounds or those otherwise hindered by co-extracted isobaric interferences 15 
without further need of coupling to other separation platforms. 16 
 17 
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1. Introduction 1 
Simple, robust and high-throughput sample preparation workflows capable of yielding reliable 2 
quantitative analysis results are highly desired for the determination of pain-management substances and 3 
drugs of abuse in biological fluids. Although dilute-and-shoot procedures have been evaluated for this 4 
purpose,[1] most assays still require a sample clean-up step (e.g. solid-phase extraction[2] or liquid-liquid 5 
extraction[3]) for removal of biological matrix components that could cause contamination of the 6 
chromatographic column or ionization suppression.[4] Solid-phase microextraction (SPME), a green 7 
technology that combines sampling, sample clean-up, and analyte enrichment into a single step, has been 8 
widely used for high-throughput  sample preparation with minimum handling[5], including in-vivo 9 
sampling, and on-site monitoring of several substances in different environmental, clinical and food 10 
applications.[6-8] Although SPME devices are capable of performing fast sample extraction from biological 11 
matrix, chromatographic separation (i.e. GC or HPLC) still is the platform of choice for the analysis of 12 
drugs of abuse,[5, 9] because the specificity may suffer from the loss of a chromatographic dimension (e.g. 13 
interferences can be observed when analyzing isomeric species with common fragment ions such as codeine 14 
and hydrocodone). Therefore, the chromatography process has become the bottleneck to further improve 15 
the analysis throughput.   16 
Differential mobility spectrometry (DMS) is a gas-phase ion separation technology based on the 17 
mobility difference of target ions under high- and low-electrical fields,[10-15] and it has been proven to be 18 
a powerful tool to improve the selectivity of  LC-MS analysis[16] and remove endogenous chemical 19 
interferences from samples to yield significant improvements in S/N and limits of detection.[17, 18] In this 20 
study, a novel DMS device is introduced for the in-line separation and quantitation of isomeric opioids with 21 
shared fragment ions (i.e. codeine and hydrocodone, Figure S1) without requiring chromatographic 22 
separation. An open-port probe (OPP) sampling interface[19-21] was used to couple the high-throughput 23 
sample preparation based on SPME and the fast analysis based on DMS/MS. Employment of the OPP 24 
system allows merging the steps of analyte desorption and elution into the instrument by simply placing the 25 
SPME device in the open-end of the system for several seconds, without employment of high-pressure parts 1 
or injection valves. Good sensitivity, accuracy, and precision were demonstrated for the targeted analytes, 2 
with total analysis time per sample ranging between 10-15 seconds when performed by high-throughput 3 
means. 4 
2. Experimental section 5 
2.1 Reagents and supplies 6 
Codeine, hydrocodone and their deuterated analogues were purchased from Cerilliant (Round Rock, 7 
TX, USA), and used without further purification. HPLC grade acetonitrile and methanol were bought from 8 
Caledon Laboratory Chemicals (Georgetown, ON, Canada). Distilled deionized water (18 MΩ) was 9 
produced in-house using a Millipore (Billerica, MA, USA) Integral 10 water purification system. Plasma 10 
samples were purchased from Bioreclamation IVT (Baltimore, MD, USA). Target analytes and internal 11 
standards (deuterated analogues) were spiked in the plasma (v/v) the day before extraction. Bio-SPME 12 
mixed mode probes (i.e. C18-SCX particles, 45 μm thickness, 15 mm coating length) were kindly provided 13 
by Millipore-Sigma (Supelco; Bellefonte, PA, USA).   14 
2.2 Open-port probe sampling interface 15 
The OPP sampling interface used in this work was constructed based on the design introduced by Van 16 
Berkel and co-workers[19], and the device is described in Figure S2. This OPP sampling interface uses a 17 
vertically aligned, co-axial tube arrangement enabling solvent delivery to the sampling end (open-port) 18 
through the tubing annulus (304 stainless steel, 1.75 mm i.d. and 3.18 mm o.d., Grainger, Lake Forest, IL, 19 
USA), and aspiration down the centre tube (PEEK, 255 µm i.d. and 510 µm o.d., IDEX, Lake Forest, IL, 20 
USA) into the ion source driven by the nebulizer gas (fixed at 90 psi) through a 635 µm i.d. nozzle, and the 21 
ESI electrode i.d. was 150 µm. The rate of the flow-in desorption solvent (methanol) was adjusted (Perkin 22 
Elmer 200 LC pump, Waltham, MA, USA) to achieve a dome-shaped sampling surface to maximize the 23 
contact area with SPME coatings (fixed at 200 µL min-1).  24 
2.3 Sample preparation with SPME and OPP sampling 1 
The workflow of SPME based sample preparation consists of several steps including fibre conditioning, 2 
analyte extraction, fibre rinsing, analyte desorption and analyte elution into the mass spectrometer. By using 3 
OPP as the MS interface for SPME, the two latter steps are combined (see Figure 1), allowing for better 4 
analysis throughput and enhanced sensitivity (i.e. minimal analyte dilution). In addition, since the step of 5 
solution transfer is eliminated, chances of additional sample loss are avoided. In this study, a preconditioned 6 
SPME fibre was first inserted in a vial containing plasma sample (250 µL) for 5 min with vortex agitation 7 
(1500 rpm). Next, the fibre with extracted target analytes was rapidly rinsed in a vessel containing 0.3 mL 8 
water for 5 seconds to remove matrix components that could have potentially adhered to the coating surface. 9 
For the above two steps, multiple samples were processed simultaneously aiming to increase the analysis 10 
speed and reduce sample-to-sample variations. Finally, the SPME fibre was placed into the sampling port 11 
containing dome-shaped continuous-flow desorption solvent (i.e. methanol) for 5 seconds, and the desorbed 12 
analytes were carried to the ESI electrode for ionization.  13 
2.4 DMS-MS system 14 
A research grade DMS system (dimension of the DMS cell was 1.5 x 20 x 63 mm, gap height x electrode 15 
width x cell length) developed by SCIEX was mounted in the atmospheric region between the Turbo VTM 16 
ion source (ESI) and the QTRAP® 5500 system’s (SCIEX, Concord ON, Canada) sampling orifice. The 17 
ESI probe was maintained at a voltage of 5500 V. A constant gas flow in the DMS cell was achieved by 18 
the curtain gas flow (N2; 20 psi, 5.5 L min-1) and the primary stage vacuum pumping of the MS system. 19 
Nitrogen was also used as the throttle gas. The temperature of the transport gas was set at 100 °C. The 20 
analysis with conventional DMS cell was performed on a QTRAP® 6500+ system equipped with 21 
SelexION+TM technology. 22 
The fundamental behaviour of DMS and the asymmetrical SV waveform10-15 has been thoroughly 23 
described in previous studies. For the experiments conducted in this study, the optimal compensation 24 
voltage (CoV) for the ion transmission was determined first by scanning the CoV from 5 V to 20 V in 0.15-1 
V increments with the separation voltage (SV) set at 6300 V (p-p). Analytes were dissolved in solution 2 
(methanol) to a concentration of 100 ng mL-1, and infused into the ESI source at a rate of 10 µL min-1. 3 
During every CoV step, multiple-reaction monitoring (MRM) signals for each analyte (Table S1) were 4 
recorded, yielding an ionogram. The optimal CoV for the transmission of each analyte through the DMS 5 
device was determined and used for the SPME-OPP sampling experiments as shown in Table S2 (fixed SV 6 
and CoV settings for each individual ions without scanning process). 7 
3. Results and discussion 8 
3.1 OPP as a direct sampling interface for SPME 9 
SPME is a high-throughput sample preparation technology. Generally, the extracted/enriched analytes 10 
on SPME devices were either thermally desorbed (thermo-stable analytes) for gas-chromatography 11 
analysis, or eluted with a high affinity solvent before introduction to HPLC or LC/MS. Aiming to further 12 
simplify the analytical workflow, various coupling approaches have been developed in the past two decades 13 
to desorb/ionize analytes from SPME devices including desorption electrospray ionization (DESI)[22], 14 
direct analysis in real time (DART),[23]  and dielectric barrier desorption ionization (DBDI)[24] which 15 
desorb analytes by exposing their surfaces to an ionizing medium (such as a gas or an aerosol).  However, 16 
some of these techniques might require sophisticated and costly equipment, need additional changes to the 17 
front-end of the instrument, or may be amenable only for a limited class of molecules (e.g. thermally labile). 18 
Other approaches have been introduced recently for the coupling of SPME with MS through direct 19 
electrospray ionization on SPME devices including SPME-nano-ESI[25], in-tube SPME-MS,[26] and 20 
coated blade-spray.[27, 28] These techniques have been well discussed in a recent review article.[29]  21 
Open-port probe (OPP) sampling interface[19] was designed to circumvent the usage of high-pressure 22 
pumps and injection valves, thus preventing common problems observed in LC applications, such as 23 
leaking and carryover, while combining the steps of analyte desorption and direct injection into the MS 24 
system. As a result, OPP has shown great potential as a simple and robust tool for the analysis of multiple 1 
types of unprocessed and complex samples, including plastic polymers, marker inks, vegetable oils, and 2 
laser-cut.[19, 20, 30]  In this work, the OPP is used for the direct interface of SPME fibres to MS by simply 3 
placing the coating into the sampling end of the port. In this setup, the extracted/enriched analytes were 4 
washed out by the elution solvent continuously flowing through the sampling interface, aspirated to the 5 
commercial ESI ion source and then analysed by the DMS-MS/MS analysis. Due to the short delay between 6 
the desorption and the ionization steps, minimal peak broadening was observed (e.g. FWHM was 7 
approximately 6 seconds for a 5-second elution process as shown in Figure 1).  8 
3.2 Isomeric separation with DMS 9 
DMS is a technology that can be used to separate gas-phase ions prior to analysis by MS.[10-15] In a 10 
DMS cell, a high frequency asymmetric waveform (SV), varying between high- and low-electric field 11 
regimes is applied across the ion transport channel between the two planner electrodes, perpendicular to the 12 
direction of the ion transport flow. The different mobilities exhibited under high- and low-electric field 13 
results in ions acquiring a “zigzag” trajectory between the electrodes. For successful transmission through 14 
the DMS cell and sampling into MS, a DC CoV can be applied to steer ions back on axis. This technology 15 
has been successfully used for both chemical noise elimination[17, 31] and isomeric ion separation (e.g. 16 
stereoisomers,[12, 17, 32, 33] structural isomers,[34-39] and even tautomers[40]).  17 
Several approaches have been introduced aiming to enhance the resolving power of DMS, by either 18 
increasing the CoV difference (∆CoV) or reducing the peak width in volts at half height (FWHM) in a CoV 19 
ramp scan. The modified transport gas has been widely used to improve the resolving power of DMS by 20 
adding a polar solvent (modifier) to the curtain gas.[41] Therefore, the analyte ions cluster with modifier 21 
molecules during the low-field portion of the waveform and undergo de-clustering during the high-field 22 
half-cycle, thus amplifying their differential mobilities with increased ∆CoV (i.e. better separation). 23 
Alcohols (e.g. methanol, isopropanol) are most frequently used as modifiers, but their high proton affinity 24 
may induce a charge stripping from the analyte, which leads to a lower sensitivity.[42]  The reduction of 25 
FWHM of a CoV peak is another approach for resolving power enhancement that is typically achieved by 1 
extending the ions’ residence time within the DMS cell by reducing transport gas flow rate with the throttle 2 
gas.[12, 43] It is important to highlight that although better separation can be attained, long in-cell ion 3 
residence time also directly leads to significant ion losses. In certain applications, chemical modifier and a 4 
throttle gas can be used simultaneously to  further improve DMS resolving power.[44]   5 
In this study, an alternative approach to enhance resolving power was developed by modifying the 6 
dimensions of the DMS cell from 1 mm x 10 mm x 30 mm (gap height x electrode width x cell length) to 7 
1.5 mm x 20 mm x 63 mm. The enlarged volume of the DMS cell extends the residence time, which reduces 8 
the FWHM of studied analytes from 3.0 V to 0.8 V (Figure S3) without application of a throttle gas. Similar 9 
FWHM could be reached with the original cell (commercial cell with smaller volume) using 34 psi of 10 
throttle gas. However, due to the small ∆CoV attained with the commercial cell (0.8 V), even when using 11 
a throttle gas of 34 psi, it was not possible to detect codeine and hydrocodone individually at their optimum 12 
sensitivity (CoV peak apex). As an alternative, the CoV can be enlarged by increasing the gap height of the 13 
DMS cell. In the presented study, owing to the larger gap between the two electrodes, CoV as well as ∆CoV 14 
were increased to 1.5x for the same field strength. Thus, the combined benefits of both reduced FHWM 15 
and increased ∆CoV enabled the complete separation of these analytes (Figure 2). As can be seen in Figure 16 
S4, the interference between codeine and hydrocodone analysis was observed to be less than one percent. 17 
Although adequate separation for these isomers was accomplished by only modifying the geometry of the 18 
DMS cell, a chemical modifier and/or throttle gas can also be implemented for more challenging 19 
applications. As an example, Figure S5 presents the separation of other opioid isomers (i.e. norcodeine, 20 
morphine, and hydromorphone) with shared fragment ions on the modified DMS cell with a 10 psi throttle 21 
gas. 22 
3.3 Isomeric separation with DMS 23 
The simultaneous quantification of codeine and hydrocodone from human plasma was chosen as the 24 
example assay to demonstrate the potential of the introduced SPME-OPP-DMS-MS platform for the fast 25 
analysis of pain management drugs from biological matrix. As shown in Figure 3 and Figure S6, our results 1 
met the analytical requirements set by the World Anti-Doping Agency (WADA). A limit of quantification 2 
(LOQ) of 1 ng mL-1 (Figure S6) and linear dynamic range between 1 and 500 ng mL-1), were demonstrated 3 
with good accuracy (85-106%) and linearity (R2 > 0.99) (Table S3). Given that SPME devices can be 4 
arrange in a high-throughput assembly (e.g. 96 samples at the same time),[45] and there is no need for 5 
additional separation step other than that offered by DMS, the analysis can be as fast as 10-15 seconds per 6 
sample.  7 
4. Conclusions 8 
A simple, robust and high-throughput technology based on SPME and DMS-MS was introduced for 9 
quantitative analysis of drugs of abuse and pain-management drugs in biofluids. Following extraction, 10 
SPME devices with isolated and enriched target analytes were directly coupled to the MS system via an 11 
OPP sampling interface, without further requirement of injection valves or high pressure parts. A modified 12 
DMS cell, with significantly improved resolving power, successfully distinguished isomeric species with 13 
shared fragment ions such as codeine and hydrocodone, without the assistance of lengthy LC gradients. 14 
The results presented here demonstrate the great potential of coupling SPME to DMS-MS in targeted 15 
analysis where regular SPME-MS, without the assistance of chromatographic separation, might fail to 16 
provide a true picture of the sample scrutinized. Similarly, this platform could be used for the application 17 
of SPME-OPP-DMS-MS towards lipids and metabolites profiling in the future.[46, 47]  18 
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Figure Captions 1 
Figure 1. Workflow for Bio-SPME-OPP-DMS-MS/MS analysis of controlled substances from complex 2 
matrices 3 
Figure 2 Ionogram generated from infusion of a methanolic solution containing a mix of codeine (a) and 4 
hydrocodone (b). The SV was set as 6300 V.  5 
Figure 3. A. Quantitative analysis of plasma spiked with codeine (1 ng ml−1 to 500 ng mL−1) and its 6 
isotopologue d3-codeine (50 ng mL−1). B. Quantitative analysis of plasma spiked with hydrocodone (1 7 
ng ml−1 to 500 ng mL−1) and its isotopologue d3-hydrocodone (50 ng mL−1). Red triangles represent the 8 
accuracy QC levels (30, 200, and 450 ng mL−1, respectively). 9 
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